Received Nov 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (NOVAVAX)) | NOVAVAX | 1 | 6315mf002c | IM / RA |
RN, writer, administered the vaccine with 1'25G needle on prefilled Nuvaxoid syringe, into Right deltoid of patient. Prior to administration, anatomy was confirmed and was seen to be WNL. Writer administered, and within a few seconds, the patient's arm, specifically where the vaccine was administered, was shown to have increased swelling with erythemia. Right deltoid area, looked as though a 'bubble' was underneath the skin. Vaccine was given with needle being fully insereted into arm, therefore, in the intramuscular area, as to ensure that administration was correctly given. Rph was also notified of adverse event, observed the area inwhich patient had unusual swelling, to draw a line around the swelling when he returns home for observation, and patient was advised to wait and additional 10 minutes in order to ensure patient safety. Patient was educated by Rph, when to seek further medical attention, if his symptoms prolonged or worsened. Patient reported understanding of direction and that he felt well at time of exit.
Unknown
Unknown
unknown
NKA
na